Translational Development Acquisition Corp. (TDAC)
NASDAQ: TDAC · Real-Time Price · USD
10.08
-0.01 (-0.10%)
Apr 2, 2025, 4:00 PM EDT - Market closed

TDAC Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022
Period Ending
Sep '24 Dec '23 Dec '22
Net Income
-0.55-0.49-0.07
Other Amortization
0.480.48-
Change in Other Net Operating Assets
0.020-0.08
Operating Cash Flow
-0.04-0-0.15
Total Debt Issued
0.27-0.34
Net Debt Issued (Repaid)
0.27-0.34
Issuance of Common Stock
--0.04
Other Financing Activities
-0.01--0.23
Financing Cash Flow
0.26-0.15
Net Cash Flow
0.22-00
Levered Free Cash Flow
-0.19-
Unlevered Free Cash Flow
--0.29-
Change in Net Working Capital
--0.01-
Updated Nov 20, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q